Found 3 hits Enz. Inhib. hit(s) with Target = 'cAMP-specific 3',5'-cyclic phosphodiesterase 4B' and Ligand = 'BDBM354688' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM354688
(US9809582, Example 33 | US9809582, Example 36 | US...)Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC2CC(C2)(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)s1 |r,wU:10.22,wD:37.39,(-7.16,-9.05,;-5.82,-9.82,;-4.49,-9.05,;-3.16,-9.82,;-1.82,-9.05,;-1.82,-7.51,;-3.16,-6.74,;-4.49,-7.51,;-5.82,-6.74,;-7.16,-7.51,;-.49,-6.74,;.85,-7.51,;2.18,-6.74,;2.18,-5.2,;.85,-4.43,;3.51,-4.43,;4.85,-5.2,;6.18,-4.43,;4.85,-6.74,;3.51,-7.51,;3.51,-9.05,;-.49,-5.2,;-1.82,-4.43,;-3.16,-5.2,;-1.82,-2.89,;-3.07,-1.99,;-2.59,-.52,;-1.05,-.52,;-.28,.81,;-1.05,2.14,;-.28,3.48,;1.21,3.87,;.81,5.36,;-.68,4.96,;2.3,4.96,;3.38,6.05,;2.69,3.48,;4.18,3.08,;4.58,1.59,;6.07,1.19,;7.16,2.28,;6.76,3.77,;5.27,4.17,;6.36,3.08,;4.98,2.28,;.41,6.85,;1.5,7.94,;1.1,9.43,;-.39,9.82,;-1.48,8.74,;-1.08,7.25,;-.58,-1.99,)| Show InChI InChI=1S/C39H41Cl2N3O7S/c1-48-32-10-8-25(16-34(32)49-2)33(17-29-30(40)21-44(47)22-31(29)41)50-37(45)36-11-9-28(52-36)20-42-27-18-39(19-27,26-6-4-3-5-7-26)38(46)51-35-23-43-14-12-24(35)13-15-43/h3-11,16,21-22,24,27,33,35,42H,12-15,17-20,23H2,1-2H3/t27?,33-,35-,39?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
CHIESI FARMACEUTICI S.p.A.
US Patent
| Assay Description
PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E... |
US Patent US9809582 (2017)
BindingDB Entry DOI: 10.7270/Q2H1345N |
More data for this
Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM354688
(US9809582, Example 33 | US9809582, Example 36 | US...)Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC2CC(C2)(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)s1 |r,wU:10.22,wD:37.39,(-7.16,-9.05,;-5.82,-9.82,;-4.49,-9.05,;-3.16,-9.82,;-1.82,-9.05,;-1.82,-7.51,;-3.16,-6.74,;-4.49,-7.51,;-5.82,-6.74,;-7.16,-7.51,;-.49,-6.74,;.85,-7.51,;2.18,-6.74,;2.18,-5.2,;.85,-4.43,;3.51,-4.43,;4.85,-5.2,;6.18,-4.43,;4.85,-6.74,;3.51,-7.51,;3.51,-9.05,;-.49,-5.2,;-1.82,-4.43,;-3.16,-5.2,;-1.82,-2.89,;-3.07,-1.99,;-2.59,-.52,;-1.05,-.52,;-.28,.81,;-1.05,2.14,;-.28,3.48,;1.21,3.87,;.81,5.36,;-.68,4.96,;2.3,4.96,;3.38,6.05,;2.69,3.48,;4.18,3.08,;4.58,1.59,;6.07,1.19,;7.16,2.28,;6.76,3.77,;5.27,4.17,;6.36,3.08,;4.98,2.28,;.41,6.85,;1.5,7.94,;1.1,9.43,;-.39,9.82,;-1.48,8.74,;-1.08,7.25,;-.58,-1.99,)| Show InChI InChI=1S/C39H41Cl2N3O7S/c1-48-32-10-8-25(16-34(32)49-2)33(17-29-30(40)21-44(47)22-31(29)41)50-37(45)36-11-9-28(52-36)20-42-27-18-39(19-27,26-6-4-3-5-7-26)38(46)51-35-23-43-14-12-24(35)13-15-43/h3-11,16,21-22,24,27,33,35,42H,12-15,17-20,23H2,1-2H3/t27?,33-,35-,39?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
CHIESI FARMACEUTICI S.p.A.
US Patent
| Assay Description
PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E... |
US Patent US9809582 (2017)
BindingDB Entry DOI: 10.7270/Q2H1345N |
More data for this
Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM354688
(US9809582, Example 33 | US9809582, Example 36 | US...)Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC2CC(C2)(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)s1 |r,wU:10.22,wD:37.39,(-7.16,-9.05,;-5.82,-9.82,;-4.49,-9.05,;-3.16,-9.82,;-1.82,-9.05,;-1.82,-7.51,;-3.16,-6.74,;-4.49,-7.51,;-5.82,-6.74,;-7.16,-7.51,;-.49,-6.74,;.85,-7.51,;2.18,-6.74,;2.18,-5.2,;.85,-4.43,;3.51,-4.43,;4.85,-5.2,;6.18,-4.43,;4.85,-6.74,;3.51,-7.51,;3.51,-9.05,;-.49,-5.2,;-1.82,-4.43,;-3.16,-5.2,;-1.82,-2.89,;-3.07,-1.99,;-2.59,-.52,;-1.05,-.52,;-.28,.81,;-1.05,2.14,;-.28,3.48,;1.21,3.87,;.81,5.36,;-.68,4.96,;2.3,4.96,;3.38,6.05,;2.69,3.48,;4.18,3.08,;4.58,1.59,;6.07,1.19,;7.16,2.28,;6.76,3.77,;5.27,4.17,;6.36,3.08,;4.98,2.28,;.41,6.85,;1.5,7.94,;1.1,9.43,;-.39,9.82,;-1.48,8.74,;-1.08,7.25,;-.58,-1.99,)| Show InChI InChI=1S/C39H41Cl2N3O7S/c1-48-32-10-8-25(16-34(32)49-2)33(17-29-30(40)21-44(47)22-31(29)41)50-37(45)36-11-9-28(52-36)20-42-27-18-39(19-27,26-6-4-3-5-7-26)38(46)51-35-23-43-14-12-24(35)13-15-43/h3-11,16,21-22,24,27,33,35,42H,12-15,17-20,23H2,1-2H3/t27?,33-,35-,39?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
CHIESI FARMACEUTICI S.p.A.
US Patent
| Assay Description
PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E... |
US Patent US9809582 (2017)
BindingDB Entry DOI: 10.7270/Q2H1345N |
More data for this
Ligand-Target Pair | |
Search and Browse
